• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2300669 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-11-21 Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd view
CYHS2401621 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2024-05-30 Shanghai Starry Pharmaceutical Co Ltd;Shanghai DDsome Laboratories Co Ltd view
CYHB2201429 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2022-08-12 Qilu Pharmaceutical (Hainan) Co Ltd view
CYHB2500689 盐酸伊立替康脂质体注射液(Ⅱ) irinotecan hydrochloride Injection Chemical Drugs(2.2) Supplementary Application 2025-04-07 Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd view
CXHL2300434 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(2.2;2.4) New Drug Application 2023-04-26 Jiangsu Hengrui Pharmaceuticals Co Ltd view
CYHS2400207 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2024-01-15 Wuxi Jiyu Shanhe Pharmaceutical Co Ltd view
CYHS2101544 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2021-08-10 Furen Hetero Onco Therapeutics Ltd view
CYHS2403130 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2024-09-20 Zhejiang Sundoc Pharmaceutical Science And Tech Co Ltd;Zhejiang Hisun Pharmaceutical Co Ltd view
CYHB2201783 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Supplementary Application 2022-09-29 Sichuan Huiyu Pharmaceutical Co Ltd view
CYHS2400818 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2024-03-13 Fresenius Kabi (Wuhan) Pharmaceutical Co Ltd view
CXHS2200019 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(2.2) New Drug Application 2022-04-25 Jiangsu Hengrui Pharmaceuticals Co Ltd view
CYHS2501187 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(3) Generic Drug 2025-03-26 CSPC OUYI Pharmaceutical Co Ltd view
JYHB2300060 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-01-20 Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd view
JYHB2300741 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-12-22 Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd view
CXHL2101304 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(2.2) New Drug Application 2021-07-20 Jiangsu Hengrui Pharmaceuticals Co Ltd view
CYHL2400136 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2024-07-08 Xi'an Libang Pharmaceutical Co Ltd view
CXHL2200080 盐酸伊立替康脂质体注射液 irinotecan hydrochloride Injection Chemical Drugs(2.2) New Drug Application 2022-02-09 Jiangsu Hengrui Pharmaceuticals Co Ltd view
JYHB2300667 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-11-21 Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd view
CYHB2401876 盐酸伊立替康脂质体注射液(Ⅱ) irinotecan hydrochloride Injection Chemical Drugs(2.2) Supplementary Application 2024-11-13 Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd view
JYHB2300061 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-01-20 Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd view